Latest clinical trials News | Page 18

AdAlta: Innovative shark-inspired antibodies to revolutionise treatments for serious disease
Gene therapy trial leads to life-changing treatment for children
Gastric cancer research backed by Health Research Council
Sleep relief for lung disease
Blood Cancer – Professor Miles Prince – World Blood Cancer Day
UOW receives $100,000 donation to support brain cancer research
Researcher focuses on essential, but often-ignored, organ in pregnancy
Innovative nerve repair process helping to restore function in paralysis
Study reveals potential therapies for aggressive lymphoma
Importance of patient voices in cancer treatment
University spinout in major partnership to commercialize treatment for invasive aspergillosis
New CEO: ‘Amazing’ staff equal great outcomes
Research boosts ‘game-changing’ technology to strengthen drug development
Swinburne research lets you meet voices in your head
McGowan Government commits $2.25 million for new clinical trials centre to open in Joondalup
Clinical Trials Day: Australians benefit as local clinical trials skyrocket on back of Covid
UNSW awarded over $13m in NHMRC clinical trials funding
Study tests link between common blood pressure pills and breast cancer
CSIRO starts work on medicinal psychedelics
Burnet Institute partners with Moderna to develop novel mRNA vaccines
Ashurst advises Atomic Oncology on series seed capital raise
TMF Cosmeceuticals Pty Ltd fined $26,640 for alleged unlawful importation of ivermectin
$375 million for new landmark Queensland Comprehensive Cancer Centre
Fellowship to boost Australia’s drug discovery capabilities
New cell therapy approach to regenerate cardiac tissue following heart attack
Immuron partner submits IND application to US FDA for new therapeutic
Fast-tracked: First in-human trial for aggressive brain tumours
Australian researchers in race to prevent prostate cancer deaths
PharmaAdvice: Why and how of reporting adverse drug reactions
First comprehensive study reveals why Australians take medicinal cannabis
Filling gaps in immune system cancer research
Major discovery provides new hope for blood cancer patients
TGA grants provisional approval to Gilead Sciences Pty Ltd to extend use of Covid treatment, VEKLURY
Enhertu approved in US for patients with HER2-positive metastatic breast cancer treated with prior anti-HER2-based regimen
Farxiga met primary endpoint in DELIVER Phase III trial, reducing risk of cardiovascular death or worsening heart failure
New senior appointments for Tessara Therapeutics
Digital health support systems help improve health for people with breast cancer
USC clinical trial of potential new influenza vaccine
$10 million investment fuels promising treatments for inflammatory lung disease
Researcher founding scientist of new biotech company launched with AUD$10m investment
Govt and Air New Zealand to trial innovative and accurate new Covid test
Government subsidy accelerates new era in prostate cancer treatment
Understanding experience of female IRD carriers
Clinical trial of potential vaccine for cytomegalovirus
‘Very optimistic’: Research offers hope for MND and Alzheimer’s gene treatment
Enhertu granted Breakthrough Therapy Designation in US for patients with HER2-low metastatic breast cancer
Millions worldwide could benefit after breakthrough trial in treatment for Alzheimer’s
New UK-based business development for Adherium